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Eur J Vasc Endovasc Surg (2010) 39, 514e517CORRESPONDENCEMagnetic Resonance Imaging for Aortic DissectionDear Editor,
We would like to congratulate the authors on their review
of imaging for thoracic aortic disease.1 However, we
would like to comment on the section regarding dissec-
tion. Multidetector contrast-enhanced computed tomog-
raphy (CT) remains the most widely available modality for
imaging patients with this disease, but has some limita-
tions which may be misleading. The images acquired are
a representation of one moment in the cardiac cycle and
these static images may not illustrate the complex
anatomical and functional changes occurring in aortic
dissection. The dimensions of the true and false aortic
lumens will vary with systole and diastole and this will
have an effect on factors such as device sizing and
determining dynamic from static obstruction. Magnetic
resonance imaging (MRI) with ECG-gating is able to give
static and dynamic high-resolution information in a single
examination.
False lumen thrombosis is accepted as an important
factor in determining the prognosis of patients presenting
with dissection, and is diagnosed on CT by the absence of
contrast in the false lumen on first pass imaging.2 A delayed
second scan may detect late enhancing structures but the
ideal timing for this will be related to both the cardiac
output and local flow conditions.
MRI is able to deliver anatomical and functional
information in a single scan and compared with multi-
detector contrast-enhanced CT and has the added
benefit of not using ionising radiation. The next gener-
ation of endoluminal devices will be more conformable
to the aortic arch and MRI generated data will allow the
use of shorter endoluminal devices in patients requiring
intervention.References
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Response to ‘Magnetic Resonance Imaging for
Aortic Dissection’
Dear Editor,
We read with great interest the commentary by RE Clough,
T Schaeffter and PR Taylor about the importance of MRA in
aortic dissections. Nevertheless, controversy concerningDOI of original article: 10.1016/j.ejvs.2009.12.035.
DOI of original article: 10.1016/j.ejvs.2009.10.008.
Correspondence 515the superiority of multidetector computed tomography
(MD-CT) versus MRI still exists.
MRI allows swift 3 D high-resolution imaging, neverthe-
less, because of the closed bore design of the magnet and
the need for patient monitoring devices MRI maybe less
adapted than CT for unstable patients.
On the other hand, despite ionizing radiation hazards
and nephrotoxicity of contrast agents, MD-CT optimized the
balance between spatial and temporal resolution and
invasiveness, hence propelling MD-CT to become the most
widely used modality in current practice, thanks to its wide
availability, speed, cost-effectiveness and efficiency.
Imaging of all phases of contrast enhancement has also
become possible using a single bolus of contrast agent, with
delayed scans to visualize the parenchyma and the late
opacification of false lumen. One significant drawback of
MD-CT is a radiation dose, nevertheless, it is possible to
reduce the radiation rate to a minimum by adequate
parameter optimization.
As said by RE Clough, PR Taylor, it is true that move-
ments of the dissected aortic intimal flap through the
cardiac cycle are not clearly visualized without ECG-gating.
On the other hand, CT without ECG-Gating is actually
sufficient for the arch and the descending aorta, allowing
a complete analysis of the thoracic and abdominal aorta in
one single step. Moreover, ECG-gated CTA can accurately
determine aortic distensibility.
In dissection, the selection of the ‘‘correct’’ Stent-graft
dimensions is crucial. In acute dissections, the diameter of
the non-dissected aortic segment immediately proximal to
the entry tear is considered the reference. Inversely, for
chronic dissection (>6 months) the intima becomes fibrotic
and thus cannot expand. In such cases, a tapered stent-
graft may be preferable and the distal diameter is easily
measured, without major aortic variation during the
cardiac phase.
RE Clough, PR Taylor said that ‘‘MRI generated data
will allow the use of shorter endoluminal devices in
patients requiring intervention’’. We don’t believe that
short stent-graft should be used anymore for dissections
in the future. It is well known that false-lumen throm-
bosis distal to the stent-graft, particularly in the distal
descending aorta, is uncommon, longer stent-grafts than
what is needed to simply cover the primary tear is the
trend.
As a whole, considering the excellent accuracy of the
two modalities, the imaging protocols for aortic diseases
should be tailored to answer specific questions, taking into
consideration the accessibility and the local expertise.
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Comment on ‘‘Endovascular Treatment of Profunda
Femoris Artery Obstructive Disease: Nonsense or
Useful Tool in Selected Cases?’’Dear Editor,
We read with great interest the article by Donas et al. on
the role of angioplasty in the treatment of profunda
femoris artery (PFA) obstructive disease.1 We were also
glad and honoured that our own study2 was mentioned in
the Discussion. Our results showed that isolated PFA
angioplasty was insufficient to support wound healing.
Donas et al. felt this to be in contrast with their own
results. Our study was very small, 21 patients were
included. However, the study of Donas et al. is even smaller
with 15 patients.
Donas et al. have also looked at studies reporting results
of surgical profundaplasties. We feel this is a good approach
to the question, but all studies mentioned by Donas et al.
were from the 1990’s or even older, such as the one by
Kalman et al.3 Our own study4 is much more recent and
based on 106 legs operated on consecutively between
January 2000 and December 2003. We therefore feel it
represents modern patient materials better than studies
which were conducted well over two decades ago. In our
study, published with a 3-year follow-up, none of the 16% of
ulcers healed after surgical profundaplasty.
We fully agree that profunda femoris revascularization
e either surgical or interventional e may have a role, but
we feel only in patients without tissue loss. Based on our
own two studies,2,4 we conclude it is not useful for
patients with the combination of critical ischaemia and
tissue loss.References
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